Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
University of California San Francisco
Give to UCSFUCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
Researchers recently identified a universal, essential biomarker for the childhood cancer neuroblastoma – and the biomarker could be a potential new target for treatment. Neuroblastoma accounts for
UCSF Health is expanding its collaboration with two hospitals in Hawaii, Hawai’i Pacific Health and Hilo Medical Center, to support a $150 million gift from Lynne and Marc Benioff that aims to increase access to high-quality medical care for Hawaii residents.
UCSF scientists may have discovered a new way to test for autism by measuring how children’s eyes move when they turn their heads.
Rather than simply hearing a string of notes, the brain is assessing them for patterns and predicting which notes will be next.
People with depression have higher body temperatures, suggesting there could be a mental health benefit to lowering the temperatures of those with depression.
Young Black and Hispanic women with multiple sclerosis fare worse than young white women with the disease. Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
Early identification of posterior cortical atrophy (PCA) may have important implications for Alzheimer’s treatment. PCA patients struggle with visual impairments like judging distances, distinguishing between moving and stationary objects and completing tasks like writing and retrieving a dropped item.
Fortified stem cells. Enhanced memory. A longevity hormone. UCSF researchers are finding out whether we can cancel – or at least delay – old age.
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.